Plague vaccine development: current research and future trends

SK Verma, U Tuteja - Frontiers in immunology, 2016 - frontiersin.org
Plague is one of the world's most lethal human diseases caused by Yersinia pestis, a Gram-
negative bacterium. Despite overwhelming studies for many years worldwide, there is no …

Prospects for new plague vaccines

VA Feodorova, MJ Corbel - Expert review of vaccines, 2009 - Taylor & Francis
The potential application of Yersinia pestis for bioterrorism emphasizes the urgent need to
develop more effective vaccines against airborne infection. The current status of plague …

Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines

P Tao, M Mahalingam, ML Kirtley, CJ van Lier… - PLoS …, 2013 - journals.plos.org
Pneumonic plague is a highly virulent infectious disease with 100% mortality rate, and its
causative organism Yersinia pestis poses a serious threat for deliberate use as a bioterror …

Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants

BD Ulery, LK Petersen, Y Phanse, CS Kong… - Scientific reports, 2011 - nature.com
An opportunity exists today for cross-cutting research utilizing advances in materials
science, immunology, microbial pathogenesis and computational analysis to effectively …

Plague prevention and therapy: perspectives on current and future strategies

R Rosario-Acevedo, SS Biryukov, JA Bozue, CK Cote - Biomedicines, 2021 - mdpi.com
Plague, caused by the bacterial pathogen Yersinia pestis, is a vector-borne disease that has
caused millions of human deaths over several centuries. Presently, human plague infections …

Progress on plague vaccine development

JA Rosenzweig, O Jejelowo, J Sha, TE Erova… - Applied microbiology …, 2011 - Springer
Yersinia pestis (YP), the gram-negative plague bacterium, has shaped human history unlike
any other pathogen known to mankind. YP (transmitted by the bite of an infected flea) …

The rise of pneumonic plague in Madagascar: current plague outbreak breaks usual seasonal mould

AA Rabaan, SH Al-Ahmed… - Journal of Medical …, 2019 - microbiologyresearch.org
Madagascar has just emerged from the grip of an acute urban pneumonic plague outbreak,
which began in August 2017, before the usual plague season of October–April and outside …

TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague

JS Lin, S Park, JJ Adamovicz, J Hill, JB Bliska, CK Cote… - Vaccine, 2010 - Elsevier
Immunization with the Yersinia pestis F1 and LcrV proteins improves survival in mouse and
non-human primate models of pneumonic plague. F1-and LcrV-specific antibodies …

Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine

S Biryukov, JL Dankmeyer, Z Shamsuddin… - Frontiers in …, 2021 - frontiersin.org
Relatively recent advances in plague vaccinology have produced the recombinant fusion
protein F1-V plague vaccine. This vaccine has been shown to readily protect mice from both …

Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not …

W Bowen, L Batra, AR Pulsifer, ES Yolcu, MB Lawrenz… - Vaccine, 2019 - Elsevier
Yersinia pestis is the causative agent of plague and is a re-emerging pathogen that also has
the potential as a biological weapon, necessitating the development of a preventive vaccine …